Clzumab 400 mg Injection
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Clzumab 400 mg Injection

Clzumab 400 mg Injection

Clzumab 400 mg Injection contains bevacizumab 400 mg and is a targeted anticancer medicine used in the treatment of certain cancers. It is used in specific treatment regimens for conditions such as colorectal, lung, kidney, and other cancers. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Bevacizumab is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF), helping reduce the formation of new blood vessels that tumors need for growth. It may be used alone or with other anticancer medicines depending on the cancer type and prescribed treatment protocol. Patients generally require monitoring for blood pressure, bleeding, wound-healing problems, and other treatment-related effects. The dose and infusion schedule are determined by the treating oncologist according to the indication and patient’s clinical condition.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Dosage Form Injection
Volume 16 mL
Route of Administration Intravenous infusion
Manufacturer Hetero Healthcare Ltd.

Product Also Known As

Clzumab 400mg Injection, Clzumab 400 mg Injection, Clzumab 400 Injection, Bevacizumab 400mg Injection, Bevacizumab 400 mg Injection, Bevacizumab Injection 400mg, Bevacizumab 400mg Vial